Navigation Links
Linguistics professor examines manufacturers' prescription drug websites
Date:6/30/2010

Dartmouth Linguistics Professor Lewis Glinert and Jon Schommer, the associate head of the Department of Pharmaceutical Care and Health Systems at the University of Minnesota, have examined the corporate websites dedicated to the 100 best-selling prescription drugs. They found a startling lack of consistency in an industry where advertising standards are regulated by the Food and Drug Administration (FDA).

"Communicating via a website is common practice today," says Glinert, "and consumers are very savvy about doing their own research on the Internet. The FDA has rules about direct-to-consumer print and television drug advertising, so we think it makes sense to also regulate websites and other marketing tools when it comes to prescription medicine. Consumers need consistent and balanced information."

Glinert presented their study, "Manufacturers' prescription drug web sites: A gray area of discourse and ethics," at the Communication, Medicine and Ethics (COMET) 2010 Conference at Boston University School of Public Health on June 28. Glinert and Schommer have previously published on the topic of direct-to-consumer drug advertising and Glinert has also presented their research at an FDA hearing.

In this paper, Glinert and Schommer found that the websites:

  • have no obvious linear narrative or 'next page' or conclusion; users move in a maze of text and navigation choices, some leading far away
  • lack a popular genre name (like infomercial), meaning that users come to them without a clear idea of how to perceive them
  • have an unpredictable mix of information and promotion, content, verbal style, visuals, and layout
  • often present safety and risk information in small font, in cumbersome un-bulleted blocks of text, detached from promotional text and videos, and below a page's scrolling 'fold'

Glinert notes that the Internet search engine Google has also been working to help consumers with their research on prescription drugs. A Google search of a prescription or generic drug name, for example Lipitor, will now display a summary and description at the top of the search results. The new feature, developed in partnership with the National Institutes of Health, links to NIH content and risk data. (Background information at: http://venturebeat.com/2010/06/22/google-health-search-adds-drug-info-upping-pharma-ad-spend/ and http://searchengineland.com/google-adds-new-health-search-feature-for-medications-44757 )

"Our research provides justification for Google's move," says Glinert. "Only time will tell if this is a major change for the better."


'/>"/>

Contact: Sue Knapp
sue.knapp@dartmouth.edu
603-646-3661
Dartmouth College
Source:Eurekalert

Related medicine news :

1. Genetic data added to archaeology and linguistics to get picture of African population history
2. NJIT professor heads panel studying sudden car acceleration
3. "How Facebook Makes Lonely People Even Lonelier" Revealed by Distinguished University of Chicago Professor in Interview with Brian Vaszily on IntenseExperiences.com
4. Sales are on the Rise for Professor McMurphy's Subliminal and Binaural Visualization iPhone Apps
5. Evidence-based medicine theory can be applied to frequent flying says US professor
6. Unequal leg length tied to osteoarthritis, says Queens professor
7. Decreasing health-care costs is focus of new informatics book by NJIT professor
8. K-State professor finds link between low oxygen levels in body and cancer-aiding protein
9. Genealogical tourism redefining leisure travel market, professor says
10. ISSA Congratulates Seminar Professor John Schaeffer
11. Biology professor becomes 5th at UH to reach prestigious AAAS status
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... Patients interested in receiving quick and effective ... Cameron, with or without a referral. The FASTBRACES system is valued for its ... patient’s case, treatment with the FASTBRACES system could be completed in 120 days ...
(Date:3/29/2017)... ANN ARBOR, Mich. (PRWEB) , ... ... ... Global Retailer and Manufacturer Alliance (GRMA) is growing as it continues developing ... the dietary supplement industry. The organization, which plans to publish the first ...
(Date:3/29/2017)... ... March 29, 2017 , ... Altima Technologies, Inc., ... network and data center assets and audio-video devices has recently updated its Visio ... shapes for free and download shapes and stencils from http://www.VisioStencils.com. , ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... oral braces. "The rubber bands used in conjunction with my braces always rubbed ... to design a way to prevent this problem." The O.B.S. was the result ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly ... assembly protocols involve many repetitive steps and often scientists require many different versions ... high-throughput needed, and results in a lower error rate and cost saving for ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  Novartis announced today ... has accepted the company,s Biologics License Application (BLA) ... an investigational chimeric antigen receptor T cell (CAR-T) ... young adult patients with B-cell acute lymphoblastic leukemia ... Novartis for a CAR-T. The priority review designation ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "South ... & Forecast" report to their offering. ... The South Korean Proton Therapy Market is expected to ... Untapped Proton Therapy Market for South Korea was ... Proton Therapy plays an important role in delivering comprehensive cancer care to ...
(Date:3/29/2017)... 29, 2017  Zynex (OTCQB: ZYXI), an innovative medical technology ... medical devices for pain management, stroke rehabilitation, cardiac monitoring ... the Company,s 2016 full-year investor webcast on Monday, April 3, ... The Company expects to file its 2016 full year ... ...
Breaking Medicine Technology: